The Roybal Center for Health Policy Sinnulation develops better models to understand the consequences of biomedical developments and social forces for health, health spending, and health care delivery. It builds on a large body of research at RAND, including a multi-year effort to identify and forecast the consequences of health status trends and medical breakthroughs over the next 30 years. Center pilots have led to more than $10 million in additional funding, numerous scientific articles directed to the health policy community, and wide dissemination of the models and findings via the internet and briefings to policymakers and researchers. The ultimate goal of the Center is to translate this existing work - as well as other, aging-related research at RAND - into policy tools that result in better health investments. The proposed renewal will support a Management Core and Pilot Core to predict the consequences of new technologies and treatments for health care spending (both public and private), health status, and longevity. Each pilot project will meet one of four objectives: (1) Research the basic determinants of costs and health status among the elderly and near elderly;(2) Develop simulation models to predict costs, health, functional status, and longevity;(3) Apply these models to assess the value of interventions or treatments;and (4) Disseminate the tools to decision makers in industry and the government. The proposed renewal would focus initially on four areas. First, we will model the consequences of Alzheimer's disease and dementia for society, and to identify the consequences of the most promising potential interventions. Second, we will build additional modules to understand the consequences for less prevalent but important diseases, starting with chronic kidney disease. Third, we will partner with the VA to pilot a simulation tool to prevent falls among the elderly. Fourth, we will modify our existing model to incorporate Medicare Part D.

Public Health Relevance

The Roybal Center for Health Policy Simulation develops and applies models and simulation tools for translational research on aging. These models and tools advance our understanding of the influence of demographic, technological, clinical, and social trends on the health status and health expenditures of older Americans.

National Institute of Health (NIH)
National Institute on Aging (NIA)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZAG1-ZIJ-3 (M2))
Program Officer
Baker, Colin S
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Southern California
Other Domestic Higher Education
Los Angeles
United States
Zip Code
Mangalmurti, Sandeep; Seabury, Seth A; Chandra, Amitabh et al. (2014) Medical professional liability risk among US cardiologists. Am Heart J 167:690-6
Trish, Erin; Joyce, Geoffrey; Goldman, Dana P (2014) Specialty drug spending trends among Medicare and Medicare Advantage enrollees, 2007-11. Health Aff (Millwood) 33:2018-24
Lowsky, David J; Olshansky, S Jay; Bhattacharya, Jay et al. (2014) Heterogeneity in healthy aging. J Gerontol A Biol Sci Med Sci 69:640-9
Barcellos, Silvia Helena; Wuppermann, Amelie C; Carman, Katherine Grace et al. (2014) Preparedness of Americans for the Affordable Care Act. Proc Natl Acad Sci U S A 111:5497-502
Goldman, Dana P; Cutler, David; Rowe, John W et al. (2013) Substantial health and economic returns from delayed aging may warrant a new focus for medical research. Health Aff (Millwood) 32:1698-705
Eibner, Christine; Goldman, Dana P; Sullivan, Jeffrey et al. (2013) Three large-scale changes to the Medicare program could curb its costs but also reduce enrollment. Health Aff (Millwood) 32:891-9
Seabury, Seth A; Chandra, Amitabh; Lakdawalla, Darius N et al. (2013) On average, physicians spend nearly 11 percent of their 40-year careers with an open, unresolved malpractice claim. Health Aff (Millwood) 32:111-9
Blume-Kohout, Margaret E; Sood, Neeraj (2013) Market Size and Innovation: Effects of Medicare Part D on Pharmaceutical Research and Development. J Public Econ 97:327-336
Romley, John A; Jena, Anupam B; O'Leary, June F et al. (2013) Spending and mortality in US acute care hospitals. Am J Manag Care 19:e46-54
Philipson, Tomas; Eber, Michael; Lakdawalla, Darius N et al. (2012) An analysis of whether higher health care spending in the United States versus Europe is 'worth it' in the case of cancer. Health Aff (Millwood) 31:667-75

Showing the most recent 10 out of 33 publications